naturalnews.com printable article

Originally published July 28 2004

European drug regulatory agency warns doctors about antidepressant drug and suicide risks, but in the U.S., the FDA remains silent

by Mike Adams, the Health Ranger, NaturalNews Editor

The European Union is warning its member nations and their physicians about the increased suicide risk from patients taking a popular anti-depressant drug known as Seroxat. This drug is said to increase the risk of suicide in young adults, and it is currently being taken by as many as 800,000 people in the UK alone.

The European regulatory agency covering drugs is now issuing a warning to all member nations and recommending that the drug be prescribed with caution to people under the age of 30, noting that "there is a possibility of an increased risk of suicide-related behavior in young adults."

The maker of this drug is U.S. pharmaceutical company GlaxoSmithKline, a company that is now facing fraud charges in the United States for concealing information from the FDA about the links between its drugs and suicidal behavior in children. GlaxoSmithKline, of course, denies that its drug causes increased suicides. However, observers who have been watching anti-depressant drugs for several years, such as myself, have noted that, in general, SSRI drugs are frequently linked to violent behavior such as the Columbine massacre in the United States, which was perpetrated by students who were taking anti-depressant drugs.

What's most interesting about this news, however, is the fact that while European countries and doctors are being warned about the suicide risk associated with this drug, in the United States the FDA remains silent on the issue, appearing to be protecting the pharmaceutical industry at the expense of public health. Even when faced with the evidence that GlaxoSmithKline had been concealing negative studies showing this increased risk, the FDA has refused to take any action in terms of banning the drug or requiring stronger labeling to warn doctors about this potential risk.

Clearly this is yet another case where the FDA is looking out for the interests of the pharmaceutical industry -- an industry that it is supposed to be regulating, not promoting. None of this is surprising, however. It is the kind of behavior that is consistent with the position and behavior of the FDA -- an agency that should quite frankly be gutted and its directors prosecuted by the FBI for crimes against the American public.


REVIEW TYPE



All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml